Response Evaluation Criteria in Cancer of the Liver

Known as: RECICL 
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version). (Kudo M, Kubo… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The Response Evaluation Criteria in Solid Tumors (RECIST) is inappropriate to assess the direct effects of treatment on… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
OBJECTIVES Sorafenib has become a standard therapy for advanced hepatocellular carcinoma following the demonstration of… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2014
2014
BackgroundTo test the hypothesis that use of the response evaluation criteria in cancer of the liver (RECICL), an improved… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2014
2014
BACKGROUND/AIMS We retrospectively evaluated the local tumor control and safety of transcatheter arterial chemoembolization (TACE… (More)
Is this relevant?
2014
2014
AIM We aimed to retrospectively examine the tolerability and efficacy of transarterial chemoembolization (TACE) in patients with… (More)
  • figure 1
  • table II
  • table I
  • table III
  • figure 2
Is this relevant?
2013
2013
AIM To evaluate the therapeutic efficacy of transcatheter arterial chemoembolization (TACE) using miriplatin emulsion in… (More)
Is this relevant?
2013
2013
BACKGROUND/AIMS To determine if hepatocellular carcinoma refractory to conventional transarterial chemoembolization (TACE… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
PURPOSE In order to detect an early response to anti-angiogenic therapy, this study aims at analyzing specific effects of a… (More)
Is this relevant?
2010
2010
The World Health Organization (WHO) criteria and Response Evaluation Criteria in Solid Tumors (RECIST) are inappropriate to… (More)
  • table 2
Is this relevant?